B+
Overall grade
B
Financial quality
The sleeper story is AI productivity gains quietly doing the heavy lifting while everyone obsesses over exchange headwinds. THC doubled their analytics team output and built governance to rapidly scale AI wins while killing failures. The obvious headline is exchange impact fears, but actual Q1 decline was only half the bear case with revenue mix dropping just 50 bps to 6%. The binding constraint is management's conservative guidance philosophy despite clear outperformance. As Sutaria said, their AI work 'enabled us to more than offset expected and unexpected headwinds.' My view changes if they raise guidance next quarter or if exchange deterioration accelerates beyond their linear assumptions.
The 30-second version
- AI productivity gains are quietly doing the heavy lifting - analytics team doubled output, ambient scribes scaling
- Exchange impact running 50% below bear case - only 6% of revenue vs 6.5% last year despite subsidy expiration
- Hospital margins held 16.7% despite respiratory admissions cratering 41% - cost flex is real
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Net Operating Revenue | $5.5B (Q4 2025) | $5.4B (Q1 2026) |
| Consolidated Adj EBITDA | $1.183B (Q4 2025) | $1.162B (Q1 2026) |
| Hospital Adj EBITDA | $603M (Q4 2025) | $678M (Q1 2026) |
| USPI Adj EBITDA | Not disclosed Q4 | $484M (Q1 2026) |
| Hospital Same-Store Admissions | Flat (Q4 2025) | +0.6% (Q1 2026) |
| USPI Same-Facility Revenue Growth | 7.2% (Q4 2025) | 5.3% (Q1 2026) |
| Hospital Revenue Per Adjusted Admission | +7.5% YoY (Q4 2025) | -1.5% YoY (Q1 2026) |
| Exchange Revenue Mix | 6.5% of revenue (Q1 2025) | 6% of revenue (Q1 2026) |
Accountability tracked
8 new promises made4 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →